Molecular mechanism of long non-coding RNA titin antisense RNA 1 regulating microRNA-134-5p/epidermal growth factor receptor axis in breast cancer cell glycolysis

ZHOU Gaojin; SHANG Liqing; YAN Jun

doi:10.7619/jcmp.20244586

Journal of Clinical Medicine in Practice > 2025 > 29(6): 62-68. > DOI: 10.7619/jcmp.20244586

ZHOU Gaojin, SHANG Liqing, YAN Jun. Molecular mechanism of long non-coding RNA titin antisense RNA 1 regulating microRNA-134-5p/epidermal growth factor receptor axis in breast cancer cell glycolysis[J]. Journal of Clinical Medicine in Practice, 2025, 29(6): 62-68. DOI: 10.7619/jcmp.20244586

Citation:

PDF (3286 KB)

Molecular mechanism of long non-coding RNA titin antisense RNA 1 regulating microRNA-134-5p/epidermal growth factor receptor axis in breast cancer cell glycolysis

1.
Department of General Surgery, the Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830028
2.
Department of General Surgery, the Seventh Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830028

More Information

Received Date: September 29, 2024
Revised Date: December 18, 2024

Graphical Abstract

Abstract

Abstract

Objective
To investigate the molecular mechanism by which long non-coding RNA (lncRNA) titin antisense RNA 1 (TTN-AS1) regulates the microRNA (miR)-134-5p/epidermal growth factor receptor (EGFR) axis in breast cancer cell proliferation, apoptosis and glycolysis.
Methods
Western blot was used to detect EGFR protein expression. Quantitative real-time polymerase chain reaction (qRT-PCR) was employed to measure the expression levels of lncRNA TTN-AS1, miR-134-5p and EGFR mRNA in breast epithelial cells MCF-10A and breast cancer cell lines MCF-7, MDA-MB-231 and SKBR-3. MDA-MB-231 cells were selected for subsequent experiments, and were divided into control, si-lncRNA TTN-AS1, si-lncRNA TTN-AS1+miR-134-5p-inhibitor and si-lncRNA TTN-AS1+EGFR-mimic groups. Cell proliferation rates were determined using the CCK-8 assay. Apoptosis rates were assessed by flow cytometry. Lactic acid, glucose and adenosine triphosphate (ATP) kits were used to detect glucose intake, lactic acid and ATP production in each group, respectively. Dual-luciferase reporter assays were performed to identify the binding sites between lncRNA TTN-AS1 and miR-134-5p, as well as between miR-134-5p and EGFR.
Results
Compared with MCF-10A cells, the expression levels of lncRNA TTN-AS1 and EGFR mRNA were significantly higher, while miR-134-5p expression was significantly lower in breast cancer cell lines (P < 0.05). Among these, MDA-MB-231 cells exhibited the highest expression levels of lncRNA TTN-AS1 and EGFR mRNA, and the lowest expression level of miR-134-5p (P < 0.05). Compared with the control group, the expression level of miR-134-5p was significantly increased, while the expression levels of lncRNA TTN-AS1, EGFR mRNA, and EGFR protein were significantly decreased in the si-lncRNA TTN-AS1 group (P < 0.05). Compared with the si-lncRNA TTN-AS1 group, the expression levels of EGFR mRNA and EGFR protein were significantly increased, and miR-134-5p expression was significantly decreased in the si-lncRNA TTN-AS1+miR-134-5p-inhibitor group and si-lncRNA TTN-AS1+EGFR-mimic group (P < 0.05). Compared with the control group, cell proliferation rates were significantly reduced in the si-lncRNA TTN-AS1 group (P < 0.05). Compared with the si-lncRNA TTN-AS1 group, cell proliferation rates were significantly increased in the si-lncRNA TTN-AS1+miR-134-5p-inhibitor group and si-lncRNA TTN-AS1+EGFR-mimic group (P < 0.05). Compared with the control group, apoptosis rates were significantly increased in the si-lncRNA TTN-AS1 group (P < 0.05). Compared with the si-lncRNA TTN-AS1 group, apoptosis rates were significantly reduced in the si-lncRNA TTN-AS1+miR-134-5p-inhibitor group and si-lncRNA TTN-AS1+EGFR-mimic group (P < 0.05). Compared with the control group, glucose uptake, lactate production and ATP generation were significantly decreased in the si-lncRNA TTN-AS1 group (P < 0.05). Compared with the si-lncRNA TTN-AS1 group, glucose uptake, lactate production and ATP generation were significantly increased in the si-lncRNA TTN-AS1+miR-134-5p-inhibitor group and si-lncRNA TTN-AS1+EGFR-mimic group (P < 0.05). The dual-luciferase reporter assay confirmed that lncRNA TTN-AS1 had a targeted binding site with miR-134-5p, and miR-134-5p has a targeted binding site with EGFR.
Conclusion
The lncRNA TTN-AS1 may negatively regulate the miR-134-5p/EGFR axis, thereby affecting the proliferation, apoptosis and glycolysis of breast cancer.
- breast cancer,
- long non-coding RNA,
- titin antisense RNA 1,
- microRNA-134-5p,
- epidermal growth factor receptor,
- glycolysis,
- cell proliferation,
- cell apoptosis

FullText(HTML)

References (17)

References

[1]	王思宇, 王宇. lncRNA UCA1和miRNAs在消化系统肿瘤中的作用机制研究进展[J]. 解放军医学杂志, 2021, 46(12): 1232-1238. doi: 10.11855/j.issn.0577-7402.2021.12.10
[2]	赵志国, 张力平. miRNA和lncRNA相互作用与恶性肿瘤相关性的研究进展[J]. 现代肿瘤医学, 2018, 26(18): 2991-2994. doi: 10.3969/j.issn.1672-4992.2018.18.040
[3]	王玲华, 陈艳, 李叶若. lncRNA TTN-AS1通过miR-138-5p/EGFR轴调控胆囊癌细胞增殖、凋亡和迁移[J]. 中国细胞生物学学报, 2023, 45(1): 64-74.
[4]	刘汉涛, 秦宏敏, 赵良虎. lncRNA TTN-AS1调控miR-134-5p/MBTD1信号轴促进骨肉瘤的生长和转移[J]. 国际检验医学杂志, 2022, 43(23): 2863-2868. doi: 10.3969/j.issn.1673-4130.2022.23.010
[5]	赵振慧, 李妍, 李迅. 长链非编码RNA TTN-AS1靶向miR-134-5p调控乳腺癌细胞的生长和转移[J]. 西部医学, 2021, 33(7): 942-948. doi: 10.3969/j.issn.1672-3511.2021.07.002
[6]	居红格, 李峰, 马俊兵, 等. 三阴型乳腺癌中RHBDD1和EGFR的表达及相关性分析[J]. 临床与实验病理学杂志, 2020, 36(4): 396-400.
[7]	王超群, 王艳, 黄必飞, 等. 三阴性和非三阴性乳腺癌中Fascin-1和EGFR表达的相关性研究[J]. 中华内分泌外科杂志, 2018, 12(2): 115-117, 145.
[8]	陈丽, 吴艳, 方梦可, 等. 利多卡因通过调控lncRNA TTN-AS1/miR-524-5p表达对骨肉瘤细胞增殖、迁移和侵袭的影响[J]. 现代肿瘤医学, 2021, 29(16): 2791-2797.
[9]	ZHENG Q X, WANG J, GU X Y, et al. TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers[J]. Biomed Pharmacother, 2021, 135: 111169.
[10]	赵晶, 李蒙, 叶成, 等. lncRNA TTN-AS1通过靶向miR-204-3p调控胃癌细胞迁移、侵袭及上皮-间质转化[J]. 温州医科大学学报, 2021, 51(10): 782-786, 792.
[11]	黄莺. 下调lncRNA TTN-AS1表达对白血病Raji细胞增殖、侵袭的影响[J]. 安徽大学学报: 自然科学版, 2019, 43(6): 102-108.
[12]	WANG S H, DONG L, MA L, et al. SQLE facilitates the pancreatic cancer progression via the lncRNA-TTN-AS1/miR-133b/SQLE axis[J]. J Cell Mol Med, 2022, 26(13): 3636-3647.
[13]	SHEN L D, WU Y Y, LI A L, et al. LncRNA TTN-AS1 promotes endometrial cancer by sponging miR-376a-3p[J]. Oncol Rep, 2020, 44(4): 1343-1354.
[14]	刘春江, 司峰志. LncRNA TTN-AS1调控miR-139-5p/PDK1/AKT/Caspase-3信号通路促进鼻咽癌的生长和转移[J]. 局解手术学杂志, 2022, 31(6): 472-478.
[15]	刘华, 张素兰, 梁天嵩, 等. lncRNA TTN-AS1通过miR-519d-3p/MMP2调控肺腺癌A549细胞的活力和侵袭[J]. 中国病理生理杂志, 2020, 36(10): 1789-1795.
[16]	余涛, 陈远香, 刘施妍, 等. BMP9下调HIF-1α抑制乳腺癌MDA-MB-231细胞的有氧糖酵解和迁移侵袭[J]. 中国药理学通报, 2024, 40(5): 840-846.
[17]	金玉, 王艳辉, 杨乐欣, 等. 953例乳腺癌患者CK5/6、EGFR和AR的表达与临床病理分析[J]. 天津医科大学学报, 2022, 28(1): 85-90.

Cited By

Cited by

Periodical cited type(11)

1.	付应娟，吴杭钦，王昊. B超引导下S-FICB联合外侧入路坐骨神经阻滞在下肢骨折术中的应用. 浙江创伤外科. 2024(09): 1787-1790 .
2.	楚建磊，盛莉，罗威. 超声引导下外周神经阻滞麻醉在下肢骨折手术中的应用效果. 中国实用医刊. 2023(14): 29-32 .
3.	李大军，杨静，于利文. 不同外周神经阻滞方法用于全膝关节置换术老年患者的效果比较. 河南外科学杂志. 2022(01): 54-57 .
4.	张宏，张徽，高龙飞，蒯建科，杨倩. 超声引导下腰骶丛神经阻滞联合全麻在高龄髋关节置换术患者中的应用效果. 临床医学研究与实践. 2022(08): 97-100 .
5.	刘卫廷，张颖，张微. 神经阻滞联合椎管内麻醉对老年患者下肢骨折手术后谵妄情况的影响. 中国医学创新. 2022(12): 60-63 .
6.	韦应晖，吴周晏，张延卓. 超声引导神经阻滞麻醉与全麻对高龄患者髋部骨折手术的效果比较. 中外医学研究. 2022(30): 1-5 .
7.	潘志高. B超引导下外周神经阻滞麻醉在老年患者下肢手术中的应用及其对患者生命体征的影响. 现代医学与健康研究电子杂志. 2021(06): 58-60 .
8.	聂杰，周书转，曹煜，王飞. B超引导下股神经阻滞对老年人全膝关节置换术患者认知功能及术后早期康复的影响. 广州医科大学学报. 2021(01): 58-61 .
9.	赵敏杰，陈彩燕. 神经阻滞复合全麻应用于老年髋关节置换术中的临床价值研究. 浙江创伤外科. 2021(02): 356-357 .
10.	李仁超，刘继东. B超引导下神经阻滞麻醉联合全麻对老年下肢骨科手术患者麻醉效果的影响. 中外医疗. 2021(20): 53-56 .
11.	王学彭. B超引导下外周神经阻滞在年龄>60岁胫腓骨远端骨折患者中的应用观察. 实用中西医结合临床. 2021(22): 77-78 .

Other cited types(0)

Get Citation

PDF

XML

Article views (7) PDF downloads (1) Cited by(11)

Turn off MathJax

Article Contents

Abstract

References

Molecular mechanism of long non-coding RNA titin antisense RNA 1 regulating microRNA-134-5p/epidermal growth factor receptor axis in breast cancer cell glycolysis

Abstract

References

Cited by

Periodical cited type(11)

Other cited types(0)

Catalog

Export File

Citation

Format

Content